CLINICAL_TRIALS
trial_result
· 2025-09-09
Clinical Trial Update: Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss [Phase 4]
Summary
Phase 4 clinical trial evaluating the role of pioglitazone and weight loss in the pathogenesis of uric acid nephrolithiasis (completed).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Nephrolithiasis, Uric Acid | Phase 4 | Status: COMPLETED